project id: TCGA-BLCA; case submitter id: TCGA-KQ-A41P; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.53; rna integrity number: 7.1; age at index: 76; days to birth: -27816; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1935; age at diagnosis: 27816; ajcc pathologic m: M1; ajcc pathologic n: N3; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1094.0; icd 10 code: C67.0; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Trigone of bladder; synchronous malignancy: No; tissue or organ of origin: Trigone of bladder; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 290.0; sample id: 4e500021-3c23-46a8-b60b-9952e5c91434; sample submitter id: TCGA-KQ-A41P-01A; portion id: 028f3f6e-d2be-4301-8917-c3e093e4c550; portion submitter id: TCGA-KQ-A41P-01A-12; slide id: 3000ad53-2134-40c4-ab7f-758610e04643; slide submitter id: TCGA-KQ-A41P-01A-01-TSA; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; section location: TOP;